Cross-Border Platform Pursuing Advanced Modalities


We are on a mission to bring innovative medicines to patients in Asia and around the world.

Our mission

Founded in 2020, Overland Pharmaceuticals is establishing a leading cross-border platform company focused on advanced modalities through strategic partnering and in-house R&D. Overland is seeded by Hillhouse Capital with access to global innovation and China biopharma ecosystem.

Overland is building an initial oncology portfolio of first-in-class ADC and allogeneic cell therapy programs for greater China and Asia through partnering with established biotechs.

Through formative R&D partnerships and in-house technology platforms, Overland will move forward the development and commercialization of the most promising advances in medicine.

We collaborate with global partners to jointly move forward cutting-edge platform programs.

Our focus on clinical unmet need and innovation

We aim to build out a pipeline based on innovative, differentiated programs that are addressing meaningful clinical unmet needs for patients and are built on cutting-edge or advanced modality platforms.

We believe a great team is the driving force behind Overland’s success.

Our career opportunities

We strive to build a team with a shared vision, strong dedication, and collaborative spirit. Overland aims to provide competitive compensation packages with comprehensive professional development resources to enable each team member’s future career growth.

Reach out to us for inquiries.

Our office locations



South San Francisco

Our email


Business development and partnering: